CTI BioPharma Corp. logo
CTI BioPharma Corp. CTIC
$ 9.09 0.0%

Quarterly report 2023-Q1
added 05-15-2023

report update icon

CTI BioPharma Corp. Balance Sheet 2011-2024 | CTIC

Annual Balance Sheet CTI BioPharma Corp.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

18.3 M - -31.5 M -21.9 M -22.4 M -13.2 M -24.7 M -71.6 M -53.6 M -58.3 M -50.4 M -44.1 M

Long Term Debt

47.9 M - 4.46 M 4.46 M 9.27 M 13.6 M 11.3 M 19.3 M 8.36 M 10.2 M - -

Long Term Debt Current

781 K 1.16 M 2.19 M 1.69 M 4.81 M 444 K 7.95 M 37.4 M 9.01 M 3.16 M - -

Total Non Current Liabilities

- - 1.17 M 9.86 M 13.8 M 19.5 M 15.4 M 24.5 M 17.5 M 30.9 M 18.1 M 16.4 M

Total Current Liabilities

81.1 M 66.7 M 17 M 18.5 M 23.1 M 19.3 M 40.6 M 72.4 M 36.3 M 20.1 M 22.7 M 17.8 M

Total Liabilities

144 M 68.7 M 18.2 M 28.4 M 36.9 M 38.8 M 56.1 M 96.9 M 53.8 M 51 M 40.8 M 34.2 M

Deferred Revenue

- - - - - 912 K 103 K 578 K 826 K 1.01 M - -

Retained Earnings

-2.52 B -2.43 B -2.33 B -2.26 B -2.22 B -2.2 B -2.15 B -2.1 B -1.98 B -1.88 B -1.83 B -1.71 B

Total Assets

126 M 72.4 M 58.2 M 46.3 M 89.8 M 54.9 M 63.8 M 144 M 92.3 M 93.7 M 73.7 M 62.2 M

Cash and Cash Equivalents

30.4 M 65.4 M 40.4 M 31.1 M 36.4 M 27.2 M 44 M 128 M 70.9 M 71.6 M 50.4 M 47.1 M

Book Value

-17.6 M 3.77 M 40 M 17.9 M 52.9 M 16.1 M 7.76 M 47.4 M 38.5 M 42.8 M 32.9 M 28 M

Total Shareholders Equity

-17.6 M 3.77 M 40 M 23.7 M 58.7 M 21.8 M 13.3 M 52 M 41.8 M 45.2 M 34.6 M 28.7 M

All numbers in USD currency

Quarterly Balance Sheet CTI BioPharma Corp.

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - 47.8 M 47.7 M - - - - - - - 2.05 M 3.25 M 4.46 M 4.46 M 4.46 M 4.46 M 9.27 M 9.27 M 9.27 M 9.27 M 13.6 M 13.6 M 13.6 M 13.6 M 11.3 M 11.3 M 11.3 M 11.3 M 19.1 M 19.1 M 19.1 M 19.1 M 8.36 M 8.36 M 8.36 M 8.36 M 10.2 M 10.2 M 10.2 M 10.2 M - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

138 M 144 M 140 M 140 M 159 M 68.7 M 62.3 M 15.8 M 16.1 M 18.2 M 18.2 M 18.2 M 18.2 M 28.4 M 28.4 M 28.4 M 28.4 M 36.9 M 36.9 M 36.9 M 36.9 M 38.8 M 38.8 M 38.8 M 38.8 M 56.1 M 56.1 M 56.1 M 56.1 M 96.8 M 96.8 M 96.8 M 96.8 M 52.4 M 52.4 M 52.4 M 52.4 M 37.5 M 37.5 M 37.5 M 37.5 M 27.3 M 27.3 M 27.3 M 27.3 M 20.8 M 20.8 M 20.8 M 20.8 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - 806 K 915 K 912 K 872 K 1.32 M 912 K 103 K 103 K 103 K 103 K 578 K 578 K 578 K 578 K 826 K 826 K 826 K 826 K 1.01 M 1.01 M 1.01 M 1.01 M - - - - - - - -

Retained Earnings

-2.53 B -2.52 B -2.5 B -2.49 B -2.46 B -2.43 B -2.39 B -2.36 B -2.35 B -2.33 B -2.33 B -2.33 B -2.33 B -2.28 B -2.28 B -2.28 B -2.26 B -2.22 B -2.22 B -2.22 B -2.22 B -2.2 B -2.2 B -2.2 B -2.2 B -2.15 B -2.15 B -2.15 B -2.15 B -2.1 B -2.1 B -2.1 B -2.1 B -1.98 B -1.98 B -1.98 B -1.98 B -1.88 B -1.88 B -1.88 B -1.88 B -1.83 B -1.83 B -1.83 B -1.83 B -1.71 B -1.71 B -1.71 B -1.71 B

Total Assets

112 M 126 M 123 M 135 M 131 M 72.4 M 101 M 77.5 M 42.8 M 58.2 M 58.2 M 58.2 M 58.2 M 46.3 M 46.3 M 46.3 M 46.3 M 89.8 M 89.8 M 89.8 M 89.8 M 54.9 M 54.9 M 54.9 M 54.9 M 63.8 M 63.8 M 63.8 M 63.8 M 144 M 144 M 144 M 144 M 92.3 M 92.3 M 92.3 M 92.3 M 93.7 M 93.7 M 93.7 M 93.7 M 73.7 M 73.7 M 73.7 M 73.7 M 62.2 M 62.2 M 62.2 M 62.2 M

Cash and Cash Equivalents

24.2 M 30.4 M 32 M 66.1 M 96.9 M 65.4 M 95.3 M 71.9 M 33.1 M 40.4 M 40.4 M 40.4 M 40.4 M 31.1 M 31.1 M 31.1 M 31.1 M 36.4 M 36.4 M 36.4 M 36.4 M 43.2 M 27.2 M 27.2 M 27.2 M 44 M 44 M 44 M 44 M 128 M 128 M 128 M 128 M 70.9 M 70.9 M 70.9 M 70.9 M 71.6 M 71.6 M 71.6 M 71.6 M 50.4 M 50.4 M 50.4 M 50.4 M 47.1 M 47.1 M 47.1 M 47.1 M

Book Value

-25.3 M -17.6 M -16.8 M -5.27 M -27.9 M 3.77 M 38.9 M 61.7 M 26.7 M 40 M 40 M 40 M 40 M 17.9 M 17.9 M 17.9 M 17.9 M 52.9 M 52.9 M 52.9 M 52.9 M 16.1 M 16.1 M 16.1 M 16.1 M 7.76 M 7.76 M 7.76 M 7.76 M 47.4 M 47.4 M 47.4 M 47.4 M 39.9 M 39.9 M 39.9 M 39.9 M 56.2 M 56.2 M 56.2 M 56.2 M 46.4 M 46.4 M 46.4 M 46.4 M 41.5 M 41.5 M 41.5 M 41.5 M

Total Shareholders Equity

-25.3 M -17.6 M -16.8 M -5.27 M -27.9 M 3.77 M 38.9 M 61.7 M 26.7 M 40 M 46.8 M 40 M 40 M 23.7 M 23.7 M 23.7 M 23.7 M 58.7 M 58.7 M 58.7 M 58.7 M 21.8 M 21.8 M 21.8 M 21.8 M 13.3 M 13.3 M 13.3 M 13.3 M 52 M 52 M 52 M 52 M 41.8 M 41.8 M 41.8 M 41.8 M 45.2 M 45.2 M 45.2 M 45.2 M 34.6 M 34.6 M 34.6 M 34.6 M 28.7 M 28.7 M 28.7 M 28.7 M

All numbers in USD currency